← Evidence map

ArticlePloS one2024

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.

Imani Bijou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38683834